Natural Alternatives International, Inc. operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Natural Alternatives International with three other
pharmaceutical manufacturers in North America:
Aurora Cannabis Inc
sales of 247.94 million Canadian Dollars [US$187.41 million]
of which 112%
Canopy Growth Corp
(226.34 million Canadian Dollars [US$171.08 million]
of which 100%
was Cannabies), and
based in Canada
(47.54 million Canadian Dollars [US$35.93 million]
During the year ended June of 2019, sales at
Natural Alternatives International were $138.29 million.
increase of 4.4%
versus 2018, when the company's sales were $132.44 million.
This was the fifth consecutive year of sales increases at Natural Alternatives International
(and since 2014, sales have increased a total of 87%).
Sales of Private Label Contract Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
9.6% in 2019, from
$110.99 million to $121.60 million.
Not all segments of Natural Alternatives International experienced an increase in sales in 2019:
sales of Patent and Trademark Licensing fell 22.2% to $16.69 million.